Literature DB >> 12361490

Therapeutic lifestyle change and Adult Treatment Panel III: evidence then and now.

Neil J Stone1, Linda Van Horn.   

Abstract

The Third Report of the National Cholesterol Education Program's Adult Treatment Panel (ATP III) has an extensive section on nonpharmacologic therapy for those with abnormal blood lipids. ATP III focused on the high-saturated fat atherogenic diet, obesity, and sedentary lifestyle and recommended a program of therapeutic lifestyle change (TLC). This review discusses several issues, including 1) why ATP III changed from the Step I and Step II diets to TLC; 2) the benefits of keeping trans fatty acid intake low and the addition of viscous fiber and plant stanol/sterol esters to reduce low-density lipoprotein cholesterol beyond that seen with the Step II diet; 3) the de-emphasis on total fat and a sharper focus on the kinds of fat ingested in the new guidelines; 4) the endorsement of regular physical activity and weight loss as important first steps in reversing the unwanted metabolic effects of the metabolic syndrome; and 5) the emphasis of health-promoting aspects of the diet that include, among other things, fish and omega-3 fatty acids. At all stages of TLC, ATP III encourages the referral to registered dietitians or other qualified nutritionists for medical nutrition therapy. TLC and the ATP III guidelines should provide guidance to practitioners who wish to get low-density lipoprotein cholesterol to goal (whether or not drugs are used), prevent or treat the metabolic syndrome, and improve the overall health of the patient.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12361490     DOI: 10.1007/s11883-002-0047-x

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  92 in total

1.  Dietary cholesterol from eggs increases the ratio of total cholesterol to high-density lipoprotein cholesterol in humans: a meta-analysis.

Authors:  R M Weggemans; P L Zock; M B Katan
Journal:  Am J Clin Nutr       Date:  2001-05       Impact factor: 7.045

2.  Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease.

Authors:  Gerald Reaven
Journal:  Circulation       Date:  2002-07-16       Impact factor: 29.690

Review 3.  Dietary fatty acids and cancer.

Authors:  D P Rose
Journal:  Am J Clin Nutr       Date:  1997-10       Impact factor: 7.045

4.  Association of dietary intake of fat and fatty acids with risk of breast cancer.

Authors:  M D Holmes; D J Hunter; G A Colditz; M J Stampfer; S E Hankinson; F E Speizer; B Rosner; W C Willett
Journal:  JAMA       Date:  1999-03-10       Impact factor: 56.272

5.  One-year effects of increasingly fat-restricted, carbohydrate-enriched diets on lipoprotein levels in free-living subjects.

Authors:  R H Knopp; B Retzlaff; C Walden; B Fish; B Buck; B McCann
Journal:  Proc Soc Exp Biol Med       Date:  2000-12

6.  Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels.

Authors:  A H Lichtenstein; L M Ausman; S M Jalbert; E J Schaefer
Journal:  N Engl J Med       Date:  1999-06-24       Impact factor: 91.245

Review 7.  Diet and coronary heart disease: clinical trials.

Authors:  M E Brousseau; E J Schaefer
Journal:  Curr Atheroscler Rep       Date:  2000-11       Impact factor: 5.113

8.  The effect of a low-fat, high-carbohydrate diet on serum high density lipoprotein cholesterol and triglyceride.

Authors:  M L Turley; C M Skeaff; J I Mann; B Cox
Journal:  Eur J Clin Nutr       Date:  1998-10       Impact factor: 4.016

9.  Do fish oils prevent restenosis after coronary angioplasty?

Authors:  A Leaf; M B Jorgensen; A K Jacobs; G Cote; D A Schoenfeld; J Scheer; B H Weiner; J D Slack; M A Kellett; A E Raizner
Journal:  Circulation       Date:  1994-11       Impact factor: 29.690

10.  Efficacy of a National Cholesterol Education Program Step 2 diet in normolipidemic and hypercholesterolemic middle-aged and elderly men and women.

Authors:  E J Schaefer; A H Lichtenstein; S Lamon-Fava; J H Contois; Z Li; H Rasmussen; J R McNamara; J M Ordovas
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-08       Impact factor: 8.311

View more
  7 in total

1.  TLC: an informatics approach to enable patients to initiate tailored lifestyle conversations with providers at the point of care.

Authors:  Jianhua Li; Sharib A Khan; Jessica Mark; Phani K Nivarthi; Rupa Misra; Connie Chan; David Kaufman; Rita Kukafka
Journal:  AMIA Annu Symp Proc       Date:  2009-11-14

2.  Uncle Sam's diet sensation: MyPyramid--an overview and commentary.

Authors:  Carol S Johnston
Journal:  MedGenMed       Date:  2005-08-02

3.  Fish oil fatty acid esters of phytosterols alter plasma lipids but not red blood cell fragility in hamsters.

Authors:  Isabelle Demonty; Naoyuki Ebine; Xiaoming Jia; Peter J H Jones
Journal:  Lipids       Date:  2005-07       Impact factor: 1.880

4.  Selecting data elements to build a patient-centric electronic health record that will support adherence to therapeutic lifestyle change.

Authors:  Connie Chan; Alwyn Cohall; David Kaufman; Sharib Khan; Rita Kukafka
Journal:  AMIA Annu Symp Proc       Date:  2008-11-06

5.  Effects of low-carbohydrate and low-fat diets: a randomized trial.

Authors:  Lydia A Bazzano; Tian Hu; Kristi Reynolds; Lu Yao; Calynn Bunol; Yanxi Liu; Chung-Shiuan Chen; Michael J Klag; Paul K Whelton; Jiang He
Journal:  Ann Intern Med       Date:  2014-09-02       Impact factor: 25.391

6.  Plant Sterol Ester of α-Linolenic Acid Attenuates Nonalcoholic Fatty Liver Disease by Rescuing the Adaption to Endoplasmic Reticulum Stress and Enhancing Mitochondrial Biogenesis.

Authors:  Hao Han; Yan Guo; Xiaoyu Li; Dongxing Shi; Tingli Xue; Linqi Wang; Yanyan Li; Mingming Zheng
Journal:  Oxid Med Cell Longev       Date:  2019-12-12       Impact factor: 6.543

7.  Clinical Evaluation of a Novel Tablet Formulation of Traditional Thai Polyherbal Medicine Named Nawametho in Comparison with Its Decoction in the Treatment of Hyperlipidemia.

Authors:  Patcharawalai Jaisamut; Channong Tohlang; Subhaphorn Wanna; Acharaporn Thanakun; Thawatchai Srisuwan; Surasak Limsuwan; Wissava Rattanachai; Jarinee Suwannachot; Sasitorn Chusri
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-03       Impact factor: 2.650

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.